Evidence map›Paper›PMID 33061673›Full record

ArticleClinical pharmacology : advances and applications2020

Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study.

Ali Reza Sobhani, Hossein Farshidi, Fariba Azarkish, Mahdiya Eslami, Ebrahim Eftekhar, Mansoor Keshavarz, Nepton Soltani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical pharmacology : advances and applications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. The Role of Txnip in Mediating Low-Magnesium-Driven Endothelial Dysfunction.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ali Reza SobhaniClinical Pathology Department, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Hossein FarshidiCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Fariba AzarkishMolecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.ORCID 0000-0001-5575-4772
Mahdiya EslamiCardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Ebrahim EftekharEndocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Mansoor KeshavarzPhysiology Department, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-4480-6324
Nepton SoltaniPhysiology Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hormozgan University of Medical Sciences · IRIsfahan University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGiven the beneficial effect of MgSO PATIENTS AND

methodsIn a randomized double-blind placebo-controlled clinical trial study, 64 patients with moderate coronary artery disease (55-69% stenosis) were selected according to angiography findings. Patients were divided into four groups including patients with one or two atherosclerotic vessels treated with MgSO

resultsSerum T3, Ca, K, homocysteine, CRP, and Mg concentrations were significantly improved in Mg-treated groups compared to placebo groups.

conclusionThe results of this study showed that despite the slight change in serum magnesium level, oral administration of MgSO

Indexed as

atherosclerosisCRPfibrinogenhomocysteineMgSO4thyroid hormones

Identifiers

PMID33061673
PMCPMC7524176
OpenAlexW3088268388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.